4//SEC Filing
NEOGENOMICS INC 4
Accession 0001144204-15-027936
$NEOCIK 0001077183operating
Filed
May 5, 8:00 PM ET
Accepted
May 6, 3:53 PM ET
Size
11.8 KB
Accession
0001144204-15-027936
Insider Transaction Report
Form 4
BRODIE STEVEN G.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2015-05-04$4.78/sh+120,000$573,600→ 120,000 totalExercise: $4.78From: 2016-05-04Exp: 2020-05-04→ Common Stock (0 underlying)
Holdings
- 4,482
Common Stock
- 50,000
Stock Option (Right to Buy)
Exercise: $1.48From: 2012-05-16Exp: 2016-05-16→ Common Stock (0 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $3.76From: 2014-04-16Exp: 2018-04-16→ Common Stock (0 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $1.69From: 2012-04-12Exp: 2017-04-12→ Common Stock (0 underlying) - 20,000
Stock Option (Right to Buy)
Exercise: $3.45From: 2015-03-05Exp: 2019-03-05→ Common Stock (0 underlying)
Footnotes (5)
- [F1]On May 16, 2011 Dr. Brodie was granted 50,000 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F2]On April 12, 2012 Dr. Brodie was granted 10,000 stock options. There was immediate vesting of 2,500 shares and then 2,500 shares will vest on the next three anniversary dates of the grant date.
- [F3]On April 16, 2013 Dr. Brodie was granted 10,000 stock options. These options will vest ratably over the next three anniversary dates of the grant date.
- [F4]On March 5, 2014 Dr. Brodie was granted 20,000 stock options. The options will vest ratably over the next three anniversary dates of the grant date.
- [F5]On May 4, 2015 Dr. Brodie was granted 120,000 stock options. The options vest ratably over the next three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001077183
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 3:53 PM ET
- Size
- 11.8 KB